Flavia Pichiorri is a clinical research specialist at City of Hope, and has made significant contributions to the field of myeloma treatment. Flavia Pichiorri’s focus on CD38 targeting therapy in multi-relapsing patients has paved the way for advancements in laboratory technology and brought hope to those suffering from myeloma. Flavia Pichiorri’s work includes conducting phase 1 trials using anti-CD38 antibodies conjugated with imaging agents and therapeutic radioisotopes. Flavia Pichiorri’s dedication to understanding myeloma dissemination and developing effective therapeutic treatments is evident in her ongoing research.